Hepatitis B News and Research

Latest Hepatitis B News and Research

Cedars-Sinai investigators create new blood test for early detection of common liver cancer

Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer-;at an early enough stage that cure is possible.

30 Aug 2022

Tattoos can induce bloodstream infections

A recent review describes the characteristics of systemic bacterial infections associated with tattoos.

28 Aug 2022

New immunological treatment against hepatitis B and D viruses shows promising results in animal models

A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models.

26 Aug 2022

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several incredible liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died of HBV-related liver diseases in 2019.

25 Aug 2022

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Researchers conducted a phase I clinical trial of IN-006, an inhaled monoclonal antibody treatment for COVID-19.

24 Aug 2022

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

A new study identified the gut microbial and immune variables linked to heterogeneous messenger ribonucleic acid (mRNA) COVID-19 vaccine responses between individuals.

11 Aug 2022

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

The current study, published online in the journal JHEP Reports, looks at PFAS, which are endocrine disruptors and potential hepatotoxins.

11 Aug 2022

Review of natural products with promising anti-SARS-CoV-2 potential

In a new study, researchers reviewed existing literature on naturally active products with therapeutic efficacy against SARS-CoV-2.

10 Aug 2022

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Primary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the United States each year. The high mortality rates can be attributed in part to the fact that a significant portion of the patients are detected at a late stage, when potentially curative treatments are no longer an option. Unfortunately, today's screening methods are not able to routinely provide accurate, early detection.

5 Aug 2022

NIH updates its strategic plan for hepatitis B research

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care.

1 Aug 2022

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Researchers assessed the knowledge, attitudes, and practices (KAP) of healthcare workers (HCWs) towards monkeypox (MPX) in Italy.

29 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.

25 Jul 2022

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

A new study compares and assesses eight de novo genome assembly software tools on actual viral next-generation sequencing data.

20 Jul 2022

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

The Centers for Disease Control and Prevention (CDC) has recommended that Novavax's COVID-19 vaccine be used as another primary series option for adults in the United States ages 18 years and older.

20 Jul 2022

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Researchers described the shedding of the monkeypox (MPX) virus (MPXV) in Barcelona city of Spain.

20 Jul 2022

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

A new analysis of reports from more than 35,000 people offers the most comprehensive assessment so far of menstrual changes experienced by pre- and post-menopausal individuals in the first two weeks after receiving the COVID-19 vaccine.

15 Jul 2022

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

The viral replication cycle is crucial for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.

4 Jul 2022

Impact of SARS-CoV-2 infection on menstrual cycle

Researchers systematically reviewed the impact of COVID-19 on the menstrual cycle.

4 Jul 2022

Hepatitis B News and Research

Latest Hepatitis B News and Research

Cedars-Sinai investigators create new blood test for early detection of common liver cancer

Tattoos can induce bloodstream infections

New immunological treatment against hepatitis B and D viruses shows promising results in animal models

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Gut microbial and immune parameters linked to heterogeneous inter-personal COVID-19 vaccine-triggered immunity

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

Review of natural products with promising anti-SARS-CoV-2 potential

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

NIH updates its strategic plan for hepatitis B research

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

Impact of SARS-CoV-2 infection on menstrual cycle

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Hepatitis B News and Research

Latest Hepatitis B News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in